Domingo, P, Stapleton, JT. The hidden threat: HBV reactivation in the era of antiretroviral therapy optimization. AIDS. 2026; 40(1)DOI:10.1097/QAD.0000000000004369. PMID:41489321. IF:3.100(Q2/4D).

Timiryasova, A, Greenberg, L, Domingo, P, Tarr, PE, Egle, A, Martin, C, Mussini, C, Wit, F, Cingolani, A, Lehmann, C, Castagna, A, Petoumenos, K, Sabin, CA, Bonnet, F, Lundgren, J, Bottanelli, M, Hosein, S, Carlander, C, Amstutz, A, Grabmeier-Pfistershammer, K, Garges, H, Marongiu, A, Young, LA, Peters, L, Ryom, L. Mortality and Non-Fatal Clinical Outcomes After the Most Common Cancers in People with HIV: A Multicohort Collaboration. Cancers. 2025; 17(24)DOI:10.3390/cancers17244000. PMID:41463249. IF:4.400(Q2/3D).

Domingo, P, Prieto, P, Pons, L. A plague like no other: beyond the buboes in Thucydides' account of the Plague of Athens. CLINICAL MICROBIOLOGY AND INFECTION. 2025; 31(10)DOI:10.1016/j.cmi.2025.05.001. PMID:. IF:8.500(Q1/1D).

Monforte, A, Imaz, A, Ferrer, J, Piatti, C, Molero, M, Rodríguez, A, Stable, CE, Navarro, M, Prieto, P, Domingo, P, Crespo, M, Güerri-Fernández, R, Moltó, J, Navarro, J. Efficacy and tolerability of BIC/TAF/FTC in people with HIV and solid and hematological neoplasms: a multicenter observational study (BIKONCO study). HIV MEDICINE. 2025; 26DOI:. PMID:. IF:3.200(Q2/4D).

Peters, L, Bannister, W, Sridhar, G, Gardizi, M, van Frankenhuijsen, M, De Scheerder, MA, Johansen, IS, Viard, JP, Duvivier, C, Bogner, J, Degen, O, Castagna, A, Staub, T, Martinez, E, Domingo, P, Moreno, S, Reikvam, DH, Parczewski, M, Knysz, B, Shivkar, Y, Brown, K, van Wyk, J, Vannappagari, V. High effectiveness and rare virologic failure in treatment-experienced individuals on long-acting cabotegravir plus rilpivirine therapy across Europe: Insights from the EuroSIDA study. HIV MEDICINE. 2025; 26DOI:. PMID:. IF:3.200(Q2/4D).

Masia, M, Domingo, P, Curran, A, Guerri-Fernandez, R, Bernal, E, Bravo, J, Revollo, B, Macias, J, Tiraboschi, JM, Montejano, R, Amador, C, Garcia-Fraile, L, Blanco, JL, Ryan, P, Torralba, M, Merino, D, Diaz-Brito, V, Galindo, MJ, Ferra, S, Villoslada, A, Losa, JE, Fanjul, FJ, Perez-Stachowski, X, Peraire, J, Portilla, J, de la Fuente, S, Dueñas, C, Vazquez, MJ, Di Gregorio, S, Gil, P, de Miguel, M, Alejos, B, Martinez, E. Virological non-inferiority and lower weight gain with DTG/3TC versus BIC/FTC/TAF: 96-week final results from the PASO-DOBLE (GeSIDA 11720) randomised, multicentre, openlabel, non-inferiority trial. HIV MEDICINE. 2025; 26DOI:. PMID:. IF:3.200(Q2/4D).

Berenguer, J, Ryan, P, Lutz, T, Martin-Carbonero, L, Pérez-Latorre, L, Vivancos, MJ, Navarro, J, Navarro-Soler, R, Ferrero, OL, Palacios, R, Wyen, C, Domingo, P, Monin, M, Camino, X, Montero-Alonso, M, Killer, A, Malin, J, De los Santos, I, Esser, S, Morano, LE, López, I, Valencia, J, Vogelmann, R, Mauss, S, Rivero, A, Elamouri, F, Hidalgo-Tenorio, C, Cielniak, I, Van Bremen, K, Pérez-Somarriba, J, Sanz, J, Rozplochowski, B, Beer, D, Baumgarten, A, Haberl, A, Galindo, MJ, Fariñas, C, Raczynska, A, Voit, F, Qurishi, N, Noe, S, Reus, S, Khaykin, P, Schneeweiss, S, Wandeler, G, Boyd, A, De Miguel, M, Bellón, JM, Parczewski, M, Rockstroh, J. Hepatocellular carcinoma screening in HIV/HBV coinfected individuals: insights from Spain, Germany, and Poland. HIV MEDICINE. 2025; 26DOI:. PMID:. IF:3.200(Q2/4D).

Ryan, P, Berenguer, J, Lutz, T, Martín-Carbonero, L, Pérez-Latorre, L, Vivancos, MJ, Navarro, J, Navarro-Soler, R, Ferrero, OL, Palacios, R, Wyen, C, Domingo, P, Monin, M, Camino, X, Montero-Alonso, M, Killer, A, Malin, JJ, De los Santos, I, Esser, S, Morano, LE, López, I, Cuevas, G, Vogelmann, R, Mauss, S, Rivero, A, Elamouri, F, Hidalgo-Tenorio, C, Cielniak, I, Van Bremen, K, Pérez-Somarriba, J, Sanz, J, Rozplochowski, B, Beer, D, Baumgarten, A, Haberl, A, Galindo, MJ, Armiñanzas, C, Raczynska, A, Voit, F, Qurishi, N, Christensen, S, Szymczak, A, Hlebowicz, M, Schwarze-zander, C, Jessen, A, Boyd, A, De Miguel, M, Bellon, JM, Parczewski, M, Rockstroh, J. Prevalence and factors associated with liver cirrhosis in people with HIV and chronic hepatitis B: a cross-sectional study in Spain, Germany, and Poland. HIV MEDICINE. 2025; 26DOI:. PMID:. IF:3.200(Q2/4D).